373 related articles for article (PubMed ID: 17043629)
1. Current status and perspectives in alpha radioimmunotherapy.
Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
[TBL] [Abstract][Full Text] [Related]
2. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
5. [Radiolabeled antibodies for cancer treatment].
Barbet J; Chatal JF; Kraeber-Bodéré F
Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Karagiannis TC
Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
[TBL] [Abstract][Full Text] [Related]
7. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based targeted radiation to pediatric tumors.
Modak S; Cheung NK
J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
[TBL] [Abstract][Full Text] [Related]
9. Current status of therapy of solid tumors.
Jhanwar YS; Divgi C
J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
[TBL] [Abstract][Full Text] [Related]
10. Overview of studies on experimental radioimmunotherapy.
Knox SJ
Cancer Res; 1995 Dec; 55(23 Suppl):5832s-5836s. PubMed ID: 7493355
[TBL] [Abstract][Full Text] [Related]
11. Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
Couturier O; Faivre-Chauvet A; Filippovich IV; Thédrez P; Saï-Maurel C; Bardiès M; Mishra AK; Gauvrit M; Blain G; Apostolidis C; Molinet R; Abbe JC; Bataille R; Wijdenes J; Chatal JF; Chérel M
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3165s-3170s. PubMed ID: 10541359
[TBL] [Abstract][Full Text] [Related]
12. Current status of therapy of solid tumors: brain tumor therapy.
Zalutsky MR
J Nucl Med; 2005 Jan; 46 Suppl 1():151S-6S. PubMed ID: 15653663
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
Humm JL
J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
[TBL] [Abstract][Full Text] [Related]
14. Treatment of infection with radiolabeled antibodies.
Dadachova E; Casadevall A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
16. Advances in cancer therapy with radiolabeled monoclonal antibodies.
Goldenberg DM; Sharkey RM
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
18. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
19. Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors.
Chatal JF; Davodeau F; Cherel M; Barbet J
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S36-40. PubMed ID: 20009292
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-radioimmunotherapy: a review of recent developments].
Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
